Sebastian Böltz

9PUBLICATIONS

38CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Mixed initiative and human-in-the-loopHaematological tumoursNanomaterials

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 23, 2026

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

|Jan 07, 2026

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Fabian Müller, Melanie Hagen, Andreas Wirsching

|Apr 17, 2025

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells.

Fabian Müller, Andreas Wirsching, Melanie Hagen

|May 05, 2023

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells.

Christina Bergmann, Fabian Müller, Jörg H W Distler

|Nov 04, 2022

Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus.

Andreas Mackensen, Fabian Müller, Dimitrios Mougiakakos

|Oct 13, 2022

Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial.

Felix Muehlensiepen, Susann May, Katharina Hadaschik

Pageof 2

Frequent Collaborators

Georg Schett

Andreas Mackensen

Fabian Müller

Maria Gabriella Raimondo

3 joint publications

Ricardo Grieshaber-Bouyer

Arif Ekici

Gerhard Krönke

Christina Bergmann

Artur Wilhelm

David Simon

Frequent Collaborators

Georg Schett

Andreas Mackensen

Fabian Müller

Maria Gabriella Raimondo